← Open Payments lookup

JORDAN GOODIN: Open Payments

NPI 1639949928 · MEXICO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$903 in 51 payments from 16 companies in 2025. Trend: 2023 $215 · 2024 $467 · 2025 $903

Food & beverage: $903
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$185
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$117
Otsuka America Pharmaceutical, Inc.5$106
Vanda Pharmaceuticals Inc.5$99
Lundbeck LLC4$75
ABBVIE INC.4$66
Alkermes, Inc.3$53
Teva Pharmaceuticals USA, Inc.2$35
Supernus Pharmaceuticals, Inc.2$34
AstraZeneca Pharmaceuticals LP2$31

Products named: INGREZZA, REXULTI, CAPLYTA, FANAPT, VRAYLAR, ABILIFY MAINTENA, VIVITROL, Qelbree.

Industry payments across MO — which companies pay providers there.